title: Improvement in in vitro fertilization outcome following in vivo synchronization of oocyte maturation in mice.
abstract: Synchronization of oocyte maturation in vitro has been shown to produce higher in vitro fertilization (IVF) rates than those observed in oocytes matured in vitro without synchronization. However, the increased IVF rates never exceeded those observed in oocytes matured in vivo without synchronization. This study was therefore designed to define the effect of in vivo synchronization of oocyte maturation on IVF rates. Mice were superovulated and orally treated with 7.5 mg cilostazol (CLZ), a phosphodiesterase 3A (PDE3A) inhibitor, to induce ovulation of immature oocytes at different stages depending on frequency and time of administration of CLZ. Mice treated with CLZ ovulated germinal vesicle (GV) or metaphase I (MI) oocytes that underwent maturation in vitro or in vivo (i.e. in the oviduct) followed by IVF. Superovulated control mice ovulated mature oocytes that underwent IVF directly upon collection. Ovulated MI oocytes matured in vitro or in vivo had similar maturation rates but significantly higher IVF rates, 2-4 cell embryos, than those observed in control oocytes. Ovulated GV oocytes matured in vitro showed similar maturation rates but significantly higher IVF rates than those observed in control oocytes. However, ovulated GV oocytes matured in vivo had significantly lower IVF rates than those noted in control oocytes. It is concluded that CLZ is able to synchronize oocyte maturation and improve IVF rates in superovulated mice. CLZ may be capable of showing similar effects in humans, especially since temporal arrest of human oocyte maturation with other PDE3A inhibitors in vitro was found to improve oocyte competence level. The capability of a clinically approved PDE3A inhibitor to improve oocyte fertilization rates in mice at doses extrapolated from human therapeutic doses suggests the potential scenario of the inclusion of CLZ in superovulation programs. This may improve IVF outcomes in infertile patients.
authors.affiliation: Baylor College of Medicine, Houston, TX 77030, USA Barz IVF Center for Embryo Research and Infertility Treatment, 40 Koyah Street, Brayate, Erbil, Iraq ahmed.taiyeb@bcm.edu.
authors.forename: Ahmed M
authors.initials: AM
authors.lastname: Taiyeb
authors.affiliation: Barz IVF Center for Embryo Research and Infertility Treatment, 40 Koyah Street, Brayate, Erbil, Iraq.
authors.forename: Saeeda A
authors.initials: SA
authors.lastname: Muhsen-Alanssari
authors.affiliation: College of Veterinary Medicine and Biomedical Sciences, Texas A&M University, College Station, TX 77843, USA.
authors.forename: W L
authors.initials: WL
authors.lastname: Dees
authors.affiliation: Barz IVF Center for Embryo Research and Infertility Treatment, 40 Koyah Street, Brayate, Erbil, Iraq.
authors.forename: Mundhir T
authors.initials: MT
authors.lastname: Ridha-Albarzanchi
authors.affiliation: College of Veterinary Medicine and Biomedical Sciences, Texas A&M University, College Station, TX 77843, USA.
authors.forename: Duane C
authors.initials: DC
authors.lastname: Kraemer
mesh_terms: D000818:Animals; D001723:Birth Rate / Q000639:trends*; D000077407:Cilostazol; D004305:Dose-Response Relationship, Drug; D004973:Estrus Synchronization / Q000379:methods*; D005260:Female; D005307:Fertilization in Vitro / Q000379:methods*; D051379:Mice; D023421:Models, Animal; D009865:Oocytes / Q000187:drug effects / Q000502:physiology*; D009866:Oogenesis / Q000187:drug effects / Q000502:physiology*; D058987:Phosphodiesterase 3 Inhibitors / Q000494:pharmacology; D011247:Pregnancy; D011270:Pregnancy, Animal / Q000502:physiology; D013480:Superovulation / Q000187:drug effects; D013777:Tetrazoles / Q000494:pharmacology
chemical_list: D058987:Phosphodiesterase 3 Inhibitors; D013777:Tetrazoles; D000077407:Cilostazol
keywords: Cilostazol; fertility; immature oocytes; in vitro fertilization; in vitro maturation; in vivo maturation; superovulation; synchronization